-
Turning up the heat: Arteta reveals 'challenges' for Arsenal stars
-
Arsenal boss Arteta 'very surprised' at Jesus blast over Barcelona move
-
F2 crash in Madrid underlines fears over 'riskiest track'
-
Czech antitrust office lets Turkey's Pegasus Airlines buy Smartwings
-
Nepal flood reconstruction bill to be $4.78 bn: foreign ministry
-
Maresca says spotlight not on him ahead of Manchester derby
-
Investors on edge as energy costs, surging bond yields roil markets
-
Philippine Coast Guard finds bodies aboard ferry after blaze
-
JUMO and Standard Bank launch Social Finance Framework to scale inclusive finance in Africa
-
UK lawmakers to vote again on failed assisted dying bill
-
Doomsday tech: could AI really kill us all?
-
India welcomes Russia, Iran leaders for BRICS summit overshadowed by war
-
Yemen's Houthis complete takeover of Bab al-Mandab area: govt official to AFP
-
Italian feminist fighter Emma Bonino dies
-
Toronto film festival kicks off with ode to political activism
-
White blazers, pink ties as North Koreans land in Japan for Asian Games
-
French comedy show 'Call my agent' makes film comeback
-
Stocks tumble as oil and inflation worries fan rate hike bets
-
Indonesia seeks to bring back baby orangutans allegedly trafficked to India
-
Tiny Elversberg 'leave Earth's orbit' as Bayern come to town
-
World Cup winner Juan Mata hangs up boots at Melbourne Victory
-
Indonesia to bring back baby orangutans allegedly trafficked to India
-
From potato chips to silicon chips: lobbies cover all in Brussels
-
Business booms as lobbyists push 'priorities' in EU capital
-
Fast-pace dance takes I.Coast's working-class streets by storm
-
All Blacks coaching great Steve Hansen joins rugby league side Manly
-
Putin in India for BRICS summit overshadowed by war
-
'Desperate' Sabalenka books US Open title clash with Rybakina
-
No jet lag for 49ers as Purdy routs Rams in Australia
-
Rybakina rallies to beat Gauff, book US Open final with Sabalenka
-
Mourinho seeking 'killer' Vinicius as Real Madrid face Rayo
-
Manchester derby poses Maresca's first big test, Chelsea aim to end Hull Honeymoon
-
Vance assails Democratic 'hatred' in fiery US midterm pitch
-
It's all coming back: Celine Dion fans gear up for Paris return
-
Celine Dion: the Quebec star's long and painful road to return
-
Fans celebrate Celine Dion's Paris return with giant karaoke
-
Stocks tumble as oil and inflation fan rate hike bets
-
'Insane' Sabalenka powers past Pegula into US Open final
-
Philippine Coast Guard battles smoke in search for ferry fire missing
-
Hong Kong sentences Tiananmen activists to between 5 and 7 years in jail
-
Researchers eye AI revolution in natural disaster forecasts
-
Yu Zidi: fearless swimming prodigy, 13, with Olympics in her sights
-
Indian filmmaker Anuparna Roy: blocked at home, feted in Europe
-
Japan feminist theatre fights misogyny in 'cute' fashion
-
Appreciation, anger await as Trump heads to Irish golf resort
-
Vance assails Democratic 'hate' in fiery US midterm pitch
-
Ronaldo takes last crack at Asian glory as Saudi teams set to dominate
-
Party leaders trade barbs before Swedish election
-
Statecraft or scripture: Why Pacific nations want Jerusalem embassies
-
China, Iran among countries that have used AI to aid spying, Anthropic says
Abortion pill at the center of US Supreme Court case
A widely used pill is at the center of the latest legal battle in America's ongoing debate over abortion.
The US Supreme Court heard arguments on Tuesday about restrictions placed by a lower court on mifepristone, which is used for medication abortions.
Here is background on the drug and its use:
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for 63 percent of the abortions in the United States last year, up from 53 percent in 2020.
While the number of medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions accounted for 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
The process in fact involves more than one pill.
The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000 for use up to seven weeks of pregnancy.
Mifepristone was later approved by the FDA for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through other means, such as vacuum aspiration.
The average cost of a medication abortion at Planned Parenthood is $580, but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consultation, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and occur when a fertilized egg grows outside the uterus.
- Where is the pill available? -
Some 20 US states have banned or restricted access to abortion, including medication abortion, since the Supreme Court's ruling in June 2022 overturning the constitutional right to the procedure.
Anti-abortion groups are seeking to restrict access to mifepristone nationwide, including in states where abortion has remained legal, but the Supreme Court appeared reluctant on Tuesday to endorse such a move.
The case before the court concerns limiting the use of mifepristone to the first seven weeks of pregnancy, instead of 10, blocking it from being distributed by mail, and requiring it to be prescribed and dispensed by a doctor.
T.Wright--AT